Sign Up to like & get
recommendations!
1
Published in 2018 at "JAMA Ophthalmology"
DOI: 10.1001/jamaophthalmol.2018.0920
Abstract: Importance Immune checkpoint inhibitors, including antiprogrammed cell death protein-1 (anti-PD-1) and antiprogrammed cell death ligand-1 (anti-PD-L1) monoclonal antibodies, have recently been introduced as a promising new immunotherapy for solid cancers. The adverse effects typically include…
read more here.
Keywords:
uveal effusion;
immune checkpoint;
anti monoclonal;
therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMC Ophthalmology"
DOI: 10.1186/s12886-020-01581-z
Abstract: Background To report an unusual case of non-nanophthalmic uveal effusion syndrome (UES) with histologically normal sclera but responsive to scleral resection. Case presentation A73-year-old man presented with a bullous retinal detachment without ciliochoroidal detachment on…
read more here.
Keywords:
uveal effusion;
effusion syndrome;
case;
non nanophthalmic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Medicina"
DOI: 10.3390/medicina57020120
Abstract: Nanophthalmic uveal effusion syndrome (UES) is an extremely rare idiopathic disease characterized by a short axial length of the eye, extremely thick sclera and choroid. These structural changes can lead to spontaneous serous detachment of…
read more here.
Keywords:
uveal effusion;
effusion syndrome;
effusion;
nanophthalmic uveal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Indian Journal of Ophthalmology"
DOI: 10.4103/ijo.ijo_1221_22
Abstract: Purpose: To describe the clinical features and treatment outcomes in spontaneous uveal effusion syndrome (UES). Methods: A 10-year retrospective chart review of UES patients from a tertiary eye center was carried out. Optical coherence tomography…
read more here.
Keywords:
uveal effusion;
clinical presentation;
treatment outcomes;
effusion syndrome ... See more keywords